Bile acids in laryngopharyngeal refluxate: Will they enhance or attenuate the action of pepsin?

@article{Ali2013BileAI,
  title={Bile acids in laryngopharyngeal refluxate: Will they enhance or attenuate the action of pepsin?},
  author={Mahmoud El-Sayed Ali and Shruti Parikh and Peter Ian Chater and Jeffrey Peter Pearson},
  journal={The Laryngoscope},
  year={2013},
  volume={123}
}
OBJECTIVES/HYPOTHESIS To assess if, as previously reported in the literature, bile acids inhibit pepsin activity, resulting in pepsin having a less important role in laryngopharyngeal damage in reflux disease. [] Key MethodSTUDY DESIGN Prospective translational research study. METHODS A total of 78 patient's fasting gastric juice samples were obtained from routine endoscopy.
Pepsin and bile acids in saliva in patients with laryngopharyngeal reflux – a prospective comparative study
TLDR
Whether levels of pepsin and bile acids in the saliva can serve as diagnostic markers of LPR is investigated.
Impact of bile acids on the severity of laryngo‐pharyngeal reflux
  • E. de Corso, S. Baroni, J. Galli
  • Medicine
    Clinical otolaryngology : official journal of ENT-UK ; official journal of Netherlands Society for Oto-Rhino-Laryngology & Cervico-Facial Surgery
  • 2020
TLDR
This study evaluated the impact of bile acids on severity of laryngo‐pharyngeal reflux and the possible correlation with esophagitis and upper airway malignancies and evaluated if salivary bile acid and molecules other than pepsin might serve as diagnostic biomarkers of LPR.
Prokinetic agents and laryngopharyngeal reflux disease: Prokinetic agents and laryngopharyngeal reflux disease: A systematic review
Our objective was to systematically identify and evaluate prospective studies providing evidence for and against the use of prokinetic agents in the treatment of laryngopharyngeal reflux (LPR)
Effects of acids, pepsin, bile acids, and trypsin on laryngopharyngeal reflux diseases: physiopathology and therapeutic targets
TLDR
For LPRD caused by different reflux substances, 24-h multichannel intraluminal impedance combined with pH-metry, salivary pepsin, bile acid and other tests should be established so that different drugs and treatment courses can be used to provide patients with more personalized treatment plans.
Pepsin: biomarker, mediator, and therapeutic target for reflux and aspiration
TLDR
Research is ongoing to develop new therapies for airway reflux that specifically target pepsin, which has been shown to cause inflammation independent of the pH of the refluxate and thus despite acid suppression therapy.
Laryngopharyngeal Reflux and Inflammatory Responses in Mucosal Barrier Dysfunction of the Upper Aerodigestive Tract
TLDR
This review describes the components and functions of the mucosal barrier and the results of LPR-induced mucosal inflammation in the UAT and discusses the dynamic alterations in the mucosa barrier that might be potential therapeutic targets for L PR-induced disorders.
Supraesophageal reflux disease: a review of the literature.
TLDR
The goal of this article is to summarize the presentation and pathogenesis of SERD and to integrate the evolving body of literature pertaining to diagnostic and treatment strategies.
Reflux Aspiration and Lung Disease
TLDR
The complex interplay between all of the above factors is not currently well understood, although is likely to play a role both in the damaging potential of refluxate as well as the frequency and volume ofReflux events.
The role of nonacid reflux in laryngopharyngeal reflux diseases
TLDR
The nonacidReflux events account for the highest proportion of laryngopharyngeal reflux events, and the consistency of the results of RSI and or RFS with all reflux Events is higher than that with only acid refluxEvents, that indicates nonacid reflux may play an important role in LPRD.
The Relationship Between Asthma and Gastro-Esophageal Reflux
The relationship between asthma and gastro-esophageal reflux has been the subject of many epidemiological studies over the past decades. But the mechanisms underlying this relationship remain
...
1
2
...

References

SHOWING 1-10 OF 23 REFERENCES
Pepsin and Carbonic Anhydrase Isoenzyme III as Diagnostic Markers for Laryngopharyngeal Reflux Disease
TLDR
The objective was to investigate the potential use of pepsin and carbonic anhydrase isoenzyme III (CA‐III) as diagnostic markers for laryngopharyngeal reflux disease.
Activity/Stability of Human Pepsin: Implications for Reflux Attributed Laryngeal Disease
TLDR
Whether pepsin has to be enzymatically active to deplete laryngeal protective proteins, carbonic anhydrase isoenzyme III (CAIII), and squamous epithelial stress protein Sep70 is determined.
Role of acid and pepsin in acute experimental esophagitis.
Laryngeal mucosa: Its susceptibility to damage by acid and pepsin
TLDR
This study aims to quantitate damage caused to laryngeal tissue by acid alone, and acid and pepsin, and to determine if the extent of this damage depends on the tissue site.
Further studies on the inhibition of pepsin by bile salts.
TLDR
Findings support the need for clinical studies to evaluate administration of bile acids to bile-diverted patients with a higher incidence of peptic ulceration.
Taurodeoxycholate modulates the effects of pepsin and trypsin in experimental esophagitis.
TLDR
It is demonstrated that bile salts present in the gastroduodenal contents of patients with reflux esophagitis have the capacity to modulate the effects of pepsin and trypsin on the esophageal mucosa.
Review article: reflux and its consequences – the laryngeal, pulmonary and oesophageal manifestations
TLDR
This poster focuses on the treatment of adults with atypical oesophageal reflux disease, which manifests as chronic cough, laryngitis, hoarseness, voice disorders and asthma.
Bile-Induced Laryngitis: Is There a Basis in Evidence?
TLDR
A saline-controlled rat model was constructed in which active component solutions of bile — taurocholic acid and chenodeoxycholic Acid — were applied to intact laryngeal mucosa at various pH levels, and inflammation scores were generated by a pathologist blinded to the solutions used.
Biomarkers and laryngopharyngeal reflux
Abstract Laryngopharyngeal reflux is a controversial but increasingly made diagnosis used in patients with a collection of often non-specific laryngeal symptoms. It is a clinical diagnosis, and its
...
1
2
3
...